22157.jpg
Global Bionic Devices Industry Research, 2023-2024 & 2030: Addressing Diverse Healthcare Needs Worldwide to Sustain Growth and Fuel Develoments
25 avr. 2024 05h29 HE | Research and Markets
Dublin, April 25, 2024 (GLOBE NEWSWIRE) -- The "Global Bionic Devices Market, By Product, By Fixation, By Technology, By End User, Country Wise Market Analysis, Key Company Profiles, Trends and...
Transplant Market
Global Transplant Market Forecast Report 2024-2029: Investment by Major Players like Abbvie and Arthrex in Organ Transplantation is Fueling Market Growth
25 avr. 2024 04h08 HE | Research and Markets
Dublin, April 25, 2024 (GLOBE NEWSWIRE) -- The "Global Transplant Market - Forecasts from 2024 to 2029" report has been added to ResearchAndMarkets.com's offering.The transplant market is expected...
Global Regenerative Medicine Market
Global Regenerative Medicine Industry Research 2023-2028: Market Driven by Wide Scope in New Therapeutic Areas and Collaborations and Partnerships
03 avr. 2024 09h43 HE | Research and Markets
Dublin, April 03, 2024 (GLOBE NEWSWIRE) -- The "Global Regenerative Medicine Market by Product (Stem Cell [Autologous, Allogenic], Immunotherapy, Gene Therapy, Tissue Engineering), Application...
eledon-logo-1230.png
Eledon Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Operating and Financial Results
28 mars 2024 16h01 HE | Eledon Pharmaceuticals, Inc.
Eledon Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Operating and Financial Results
eledon-logo-1230.png
Eledon Pharmaceuticals Announces 12th Participant Enrolled in Phase 2 BESTOW Trial Evaluating Tegoprubart for the Prevention of Organ Rejection
25 mars 2024 16h56 HE | Eledon Pharmaceuticals, Inc.
Eledon Pharmaceuticals Announces 12th Participant Enrolled in Phase 2 BESTOW Trial Evaluating Tegoprubart for the Prevention of Organ Rejection
eledon-logo-1230.png
Eledon Pharmaceuticals Announces Use of Tegoprubart in First-ever Transplant of Genetically Modified Kidney from a Pig to a Human
21 mars 2024 10h31 HE | Eledon Pharmaceuticals, Inc.
Eledon Pharmaceuticals Announces Use of Tegoprubart in First-ever Transplant of Genetically Modified Kidney from a Pig to a Human
Asia-Pacific Organ Transplant Diagnostics Market
Asia-Pacific Organ Transplant Diagnostics Market Forecast to Reach $3.45 Billion by 2033 - Advancements in Human Leukocyte Antigen (HLA) Typing Tests Present Opportunities
08 mars 2024 09h37 HE | Research and Markets
Dublin, March 08, 2024 (GLOBE NEWSWIRE) -- The "Asia-Pacific Organ Transplant Diagnostics Market: Analysis and Forecast, 2023-2033" report has been added to ResearchAndMarkets.com's offering.In...
Global Bionic Devices Market
Bionic Devices Market Report 2024-2030: Lucrative Opportunities in Auditory Bionic/Cochlear Implants
05 mars 2024 11h20 HE | Research and Markets
Dublin, March 05, 2024 (GLOBE NEWSWIRE) -- The "Bionic Devices Market, Size, Global Forecast 2024-2030, Industry Trends, Share, Growth, Insight, Impact of Inflation, Company Analysis" report has...
European Organ Transplant Diagnostics Market
Europe Organ Transplant Diagnostics Market - Comprehensive Analysis and Forecast 2023-2033
30 janv. 2024 04h54 HE | Research and Markets
Dublin, Jan. 30, 2024 (GLOBE NEWSWIRE) -- The "Europe Organ Transplant Diagnostics Market: Analysis and Forecast, 2023-2033" report has been added to ResearchAndMarkets.com's offering. The Europe...
eledon-logo-1230.png
Eledon Pharmaceuticals to Present at Noble Capital Markets' Emerging Growth Equity Conference
29 nov. 2023 16h05 HE | Eledon Pharmaceuticals, Inc.
Eledon Pharmaceuticals to Present at Noble Capital Markets' Emerging Growth Equity Conference